Santarus Reviews

13 Reviews
13 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Santarus President, CEO, and Director Gerald T. Proehl
Gerald T. Proehl
9 Ratings

    its ok

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Santarus full-time for more than a year


    small pond, you can really achieve something here if you can save them


    never sure who is running the show. The owners do not want to do the hard work needed to make it successful.

    Doesn't Recommend
    No opinion of CEO

Santarus Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Specialty Sales Professional Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied through an employee referral. The process took 2 weeks - interviewed at Santarus.

    Interview Details

    Phone interview with local inVentiv recruiter, phone interview with hiring District Sales Manager, face to face interview with Regional Sales Director, hiring District Sales Manager, and inVentiv ERM.

    Interview Questions
    Accepted Offer
    Positive Experience
    Average Interview

Santarus Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters San Diego, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (AUD) per year

Santarus is a bit controlling, but in this case it's okay. Santarus' flagship drug Glumetza improves glycemic control for type 2 diabetes patients and is marketed through a partnership with Depomed. It markets a similar drug, Cycloset, also to improve glycemic control for type 2 diabetes, through a distribution and license agreement with S2 Therapeutics and Veroscience. Santarus' lead product used to be Zegerid, a modified version of omeprazole, the proton pump inhibitor found in AstraZeneca's best-selling Prilosec for heartburn. But when Zegerid's patent ran out and its... More

Worked for Santarus? Contribute to the Community!